Neurotoxic anticancer drugs, such as platinum-based anticancer drugs, taxanes, vinca
alkaloids, and proteasome/angiogenesis inhibitors are responsible for chemotherapy …

With a 3‐fold increase in the number of cancer survivors noted since the 1970s, there are
now over 28 million cancer survivors worldwide. Accordingly, there is a heightened …

The peripheral nervous system can be vulnerable to the toxic action of several drugs since it
is not protected as effectively as the central nervous system from noxious exogenous agents …

Neurotoxic side effects of cancer therapy are second in frequency to hematological toxicity.
Unlike hematological side effects that can be treated with hematopoietic growth factors …

Chemotherapy-induced peripheral neurotoxicity (CIPN) is a common, potentially severe and
dose-limiting adverse effect of cancer treatment; however, the effects of CIPN on the daily life …

Peripheral neuropathy (PN) is one of the most important complications of multiple myeloma
(MM) treatment. PN can be caused by MM itself, either by the effects of the monoclonal …

Neuroinflammation is a proinflammatory cytokine-mediated process that can be provoked by
systemic tissue injury but it is most often associated with direct injury to the nervous system …

Chemotherapy-induced peripheral neuropathy is a common side effect of selected
chemotherapeutic agents. Previous work has suggested that patients often under report the …

In multiple myeloma, peripheral neuropathy has for a long time been considered as mainly
secondary to the plasma cell dyscrasia itself. With the advent of new targeted drugs such as …

Purpose Peripheral neuropathy frequently limits the duration of treatment with thalidomide
for patients with multiple myeloma. We assessed the time course of occurrence, possible …